AMENDED AND RESTATED SUPPLY AGREEMENT BETWEEN PLANTEX USA, INC. AND PUREPAC PHARMACEUTICAL CO. DATED: APRIL 26, 2004Supply Agreement • August 5th, 2004 • Alpharma Inc • Pharmaceutical preparations • New York
AMENDED AND RESTATED SUPPLY AGREEMENT (this "Agreement") made as of April 26, 2004, between PLANTEX USA, INC., a corporation incorporated and existing under the laws of the State of New Jersey with its principal offices at 2 University Plaza, Suite 305, Hackensack, New Jersey 07601 (hereinafter called "Plantex"), and PUREPAC PHARMACEUTICAL CO., a corporation incorporated and existing under the laws of the State of Delaware with its principal offices at 200 Elmora Avenue, Elizabeth, New Jersey 07207 (hereinafter called "Purepac");
SELECTIVE WAIVER AGREEMENT BY AND BETWEEN ALPHARMA, INC. , AND TEVA PHARMACEUTICAL INDUSTRIES LTD. DATED APRIL 26, 2004Selective Waiver Agreement by And • August 5th, 2004 • Alpharma Inc • Pharmaceutical preparations • New York
AMENDMENT NO. 4 TO THE CREDIT AGREEMENTThe Credit Agreement • August 5th, 2004 • Alpharma Inc • Pharmaceutical preparations • New York
Alpharma Operating Corporation, a Delaware corporation (the "Company"), Alpharma USPD Inc., a Maryland corporation (together with the Company and the Subsidiary Borrowers party thereto, the "Borrowers"), Holdings, the Lender Parties and the Administrative Agent have entered into a Credit Agreement dated as of October 5, 2001, as amended by Amendment No. 1 dated as of December 16, 2002, Amendment No. 2 dated as of April 3, 2003 and Amendment No. 3 dated as of December 18, 2003 (as further amended, supplemented or otherwise modified from time to time, the "Credit Agreement"). Capitalized terms not otherwise defined in this Amendment have the same meanings as specified in the Credit Agreement. Holdings and the Required Lenders have agreed to amend the Credit Agreement as hereinafter set forth.
AMENDMENT NO. 5 TO THE CREDIT AGREEMENTCredit Agreement • August 5th, 2004 • Alpharma Inc • Pharmaceutical preparations • New York
Alpharma Operating Corporation, a Delaware corporation (the "Company"), Alpharma USPD Inc., a Maryland corporation (together with the Company and the Subsidiary Borrowers party thereto, the "Borrowers"), Holdings, the Lender Parties and the Administrative Agent have entered into a Credit Agreement dated as of October 5, 2001, as amended by Amendment No. 1 dated as of December 16, 2002, Amendment No. 2 dated as of April 3, 2003, Amendment No. 3 dated as of December 18, 2003 and Amendment No. 4 dated as of April 19, 2004 (as further amended, supplemented or otherwise modified from time to time, the "Credit Agreement"). Capitalized terms not otherwise defined in this Amendment have the same meanings as specified in the Credit Agreement. Holdings and the Required Lenders have agreed to amend the Credit Agreement as hereinafter set forth.
